A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

NCT00207727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: CNTO 1275

Sponsor

Centocor, Inc.

Collaborators

[object Object]